Innovaderma Share Discussion Threads

[j777j] 09/2/2017 07:19

Only £700,000 cash in the bank.

[king kong dong] 09/2/2017 07:19

You have to look forward not back in this business che!

[andyr42] 09/2/2017 07:17

che7 you are sad and bad man. Anyone can see these are the best set of results and announcements that could possibly have been made. It they continue in the same way then this is an easily 100m+ company which means the share price target over £10. My thoughts only

[qs99] 09/2/2017 07:16

this is an early stage business and IMO it appears to be delivering pretty well to what it said it was going to do. Anyone who wants 500% growth every update is deluded, but likewise those knocking this because it showed "only" £3.2m sales to Dec are also. Jan-Jun 17 are the key IMO to proving whether this has a scalable product and "record ever monthly sales" is about as much as they can say as there has only been one month since it last updated!! the fact they are reporting 9 Feb also IMO says they have good financial oversight to report so quickly, there are a lot of firms who take 4-5 months! FDA approval will also if it comes provide a boost this year.

So not without its risks, but all to play for IMO/DYOR

[doc robinson] 09/2/2017 07:16

The post end trading for Jan 17 is the critical point showing best month ever in a traditional quiet period. A lot to look forward to this year !

[che7win] 09/2/2017 07:14

Fund raising needed

[andyr42] 09/2/2017 07:12

Great results and outlook fantastic, the business is very strong. I don't think they could have done any better. I gobsmacked by what they have done so far, really beyond what I expected. DYOR

[che7win] 09/2/2017 07:09

Poor set of resultsMoved from a profit to Losses. Expenses rising and revenue growth very dissappointing, no wonder the price has been falling

[zagrosfold] 09/2/2017 07:08

Back over £2 today. Get in!

[king kong dong] 09/2/2017 07:06

Yes....all sounds very positive for the period ahead.

This is a very straight-forward business - women love tanning products and hate cellulite, so will spend anything, AND tell their friends, if its any good.

Getting in now while the price is low seems to be a reasonable strategy.

[andyr42] 09/2/2017 07:06

InnovaDerma PLC Half-year Report
09/02/2017 7:00am
UK Regulatory (RNS & others)

TIDMIDP

RNS Number : 3936W

InnovaDerma PLC

09 February 2017



InnovaDerma PLC
("InnovaDerma", the "Company" or the "Group")
Unaudited Half Year Results for the six months ended
31 December 2016

InnovaDerma (LSE: IDP), a UK developer of 'at-home'
and clinically proven treatments for hair loss,
hair care, self-tanning and skin rejuvenation, is
pleased to announce its unaudited half year results
for the period ended 31 December 2016.

The Company undertook a number of strategic actions
in the first half of the year to ensure the business
has a solid foundation for long-term growth and
infrastructure in place to enable it to scale up
effectively. These actions have begun to have a
positive financial impact, with January 2017 delivering
the highest monthly revenue ever recorded. This,
together with the seasonality of the business being
second-half weighted, means the Board is confident
of delivering a robust second half of the year.

Financial and Operational Highlights:

* Group revenue grew strongly by 125.5% to GBP3.187m
(HY2015: GBP1.414m) driven by the successful
penetration of the UK market through Superdrug and
Direct To Consumer ('DTC') sales (1)


* Gross profit increased significantly by 131% to
GBP1.837m (HY2015: GBP0.795m)


* Loss before tax of GBP0.154m (HY2015: GBP0.004m) as a
result of one-off exceptional listing costs and
strategic initiatives to expand and scale the
business


* Strategic decision to move production to the UK from
Australia to improve supply chain and operating
margins now fully implemented


* Strengthened team to drive and support international
growth in the UK, US and Australia


* Superdrug has increased shelf space for Skinny Tan on
average by a factor of four since January 2016 which
has increased its visibility in their stores and
enhanced the performance of the UK business


* Entered the US market and secured retail and e-tailer
distribution deals


* Two successful fundraising and placings raising a
total of GBP1.340m to support growth in the UK,
European and US markets and ensure adequate levels of
stock to meet growing demand


* At 31 December 2016, the Group carried a cash balance
of GBP0.701m against an opening balance of GBP0.115m


* Skinny Tan brand extended to 33 products (FY2016: 25)
to take advantage of the brand's growing popularity


* As at 31 December 2016, the Company had circa 3,360
retail points (FY2016: 2,500) and distribution in 9
countries including Skinny Tan and Leimo products


* Growing DTC platform driving financial performance,
attracting new customers and removing over-reliance
on retail chains for growth



(1 The Company recorded higher sales than indicated
in the trading statement announced on 16 January
2017 as a result of the change from reporting in
Australian Dollars to Pound Sterling, currency translations,
in addition to higher sales.)

Post Period End and Outlook
* Very strong start to the second half of the year with
January 2017 delivering the highest ever monthly
sales in what is considered to be the slowest month
in the self-tanning industry


* Manufacturing move to UK resulted in significant
availability of inventory to service orders from both
retail and DTC channels


* US performing in line with expectations after
launching in November 2016 with the Group securing
opening orders for Skinny Tan from Harmon Retail
Chain (a subsidiary of Bed Bath and Beyond).


* Opening order for the Professional Salon Range of
Skinny Tan in the US through Artisan Tan was achieved
in January


* A high degree of focus on product and inventory
planning to cater for significant & consistent demand
in the Skinny Tan Professional Salon Range in all
regions


* New products developed in the haircare category to
complement and expand our current product depth


* Development of a new self-tanning brand consisting of
a range of products with a unique sales proposition
for the multi-national grocery and mass market
retailer channels. The product range is aimed at the
more price conscious consumer and is expected to be
launched in 2017 throughout multiple markets globally


* Leimo Headmaster project continues on track with FDA
approval expected in the middle of the year and
product launch towards the end of 2017


* Revenue and profit expected to grow in the second
half driven by the above-mentioned strategic
initiatives undertaken in 2016, the fast-growing DTC
platform and expansion in the UK, Europe and US



Haris Chaudhry, Executive Chairman said

"The Board undertook a number of strategic actions
to ensure the business has a strong platform for
significant growth in 2017 and beyond and these
initiatives have already begun to bear fruit. Our
fast growing product portfolio, vastly improved
supply chain, improving margins with the relocation
of manufacturing to the UK, and recent addition
of highly talented and experienced senior management
team for key markets, are expected to deliver measurable,
sustainable and marked improvements across the business.

"I am pleased with the sound structural changes
made in the first half which has contributed to
a strong start to the second half. We are confident
in our immediate and long term prospects and of
emerging as a fast-growing international business
with a diverse portfolio in the beauty, cosmetics
and personal care space."

[andyr42] 09/2/2017 07:04

wow what a results ...
with January 2017 delivering
the highest monthly revenue ever recorded. This,
together with the seasonality of the business being
second-half weighted, means the Board is confident
of delivering a robust second half of the year.

[nw99] 08/2/2017 19:30

Ordered more my wife says the product is amazing You sent a payment of £33.98 GBP to Skinny Tan Pty Ltd.

[csmwssk12hu] 08/2/2017 16:05

So anything over 6m revenue should be a rise anything below should be a fall, interesting day tomorrow then

[susiebe] 08/2/2017 15:30

mms saying thanks very much!Tomorrow should be interesting.

[nw99] 08/2/2017 12:13

Trouble with this dip buying is you don't get many shares

[luminoso] 08/2/2017 11:06

Ah, right. Don't you just love AIM !

[che7win] 08/2/2017 10:44

Lum, No Meldex(Bioprogress), a fraud that the authorities were complicit in.

[luminoso] 08/2/2017 10:28

Che7win. MDX ? Not the glorious retractable hyperdermic needle company, Medisys ?
I lost money on them too !

[nw99] 08/2/2017 10:22

Bought the dip

[che7win] 08/2/2017 10:16

Wigan,
Good post, I have also been bitten many times, it's going through that experience which makes one look at the downside.

Bitten by dogs and frauds like IOF, TPL, MDX and am more cautious these days. It's certainly paid off for me this past 6 months.

I only play when the odds are in my favour now, don't fall in love with a company and don't go too overweight in high risk stocks! I have exactly the same view as you, if I miss this one, who cares? Another opportunity just around the corner.

To be frank, I have no funds to invest here anyway, actually on some t20s elsewhere, so Im posting here out of interest in being a past holder and you and I have a valid view as anyone else does.

[luminoso] 08/2/2017 10:03

Yes, massive head and shoulders, but real key to next share price move is funding. We know growth recently was disappointing, so now we need to know how it will be boosted and where the money's coming from. God, I'm a broken record !